Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL® and iovera° of $48.0 Million for November 2021
December 07, 2021 08:00 ET
|
Pacira BioSciences
-- EXPAREL average daily sales for November 2021 - 122% of November 2020 – TAMPA, Fla., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its...
Pacira BioSciences to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
November 23, 2021 08:00 ET
|
Pacira BioSciences
TAMPA, Fla., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the Piper Sandler 33rd Annual...
Pacira BioSciences Completes Acquisition of Flexion Therapeutics and Strengthens Leadership Position in Non-Opioid Pain Management
November 19, 2021 08:40 ET
|
Pacira BioSciences
-- Adds highly complementary ZILRETTA® to Pacira commercial offering -- -- Combined portfolio offers end-to-end non-opioid solutions along the pain pathway -- TAMPA, Fla. and BURLINGTON, Mass., Nov....
Pacira BioSciences to Present at the Jefferies London Healthcare Conference
November 10, 2021 08:00 ET
|
Pacira BioSciences
TAMPA, Fla., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the Jefferies London Healthcare...
Pacira BioSciences Reports Preliminary Net Product Sales of $44.3 Million for October 2021
November 09, 2021 08:00 ET
|
Pacira BioSciences
TAMPA, Fla., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today...
Pacira Files Lawsuit Against eVenus for Patent Infringement
November 08, 2021 16:30 ET
|
Pacira BioSciences
TAMPA, Fla., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today...
Pacira BioSciences Reports Third Quarter 2021 Financial Results
November 03, 2021 08:00 ET
|
Pacira BioSciences
-- Third quarter GAAP net income of $17.7 million and adjusted EBITDA of $48.1 million -- -- Conference call today at 8:30 a.m. ET -- TAMPA, Fla., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Pacira...
Pacira Receives Notice of Allowance for New Patent Covering EXPAREL Composition
November 02, 2021 07:30 ET
|
Pacira BioSciences
-- Patent eligible for Orange Book listing will provide additional protection into 2041 -- TAMPA, Fla., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry...
Pacira to Report Third Quarter 2021 Financial Results on Wednesday November 3, 2021
October 27, 2021 07:30 ET
|
Pacira BioSciences
PARSIPPANY, N.J., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its third quarter financial results before the open of the U.S. markets...
Pacira BioSciences to Acquire Flexion Therapeutics Further Expanding Leadership Position in Non-Opioid Pain Management
October 11, 2021 07:00 ET
|
Pacira BioSciences
-- Adds highly complementary ZILRETTA® to Pacira commercial offering -- -- Combined portfolio offers end-to-end non-opioid solutions along the pain pathway -- -- Further enhances topline revenue...